Testosterone and Erectile Function: An Unresolved Enigma

European Urology

Volumn 52, Issue 1, 2007, Pages 26-28

  Hatzimouratidis, Konstantinos ^a   Hatzichristou, Dimitrios ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE INHIBITOR; CLOMIFENE CITRATE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; PRASTERONE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE;

ANDROGEN DEFICIENCY; ATROPHY; CASTRATION; CELL STRUCTURE; CLINICAL FEATURE; CLINICAL TRIAL; CORPUS CAVERNOSUM; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; EDITORIAL; HUMAN; HYPOGONADISM; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PENIS ERECTION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SCREENING TEST; SEXUAL DEVELOPMENT; SEXUAL DYSFUNCTION; SMOOTH MUSCLE RELAXATION; TREATMENT RESPONSE;

HUMANS; HYPOGONADISM; IMPOTENCE; MALE; PENILE ERECTION; TESTOSTERONE;

EID: 34249068862     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.03.025     Document Type: Editorial

References (10)

1. Traish A.M., and Guay A.T. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 3 (2006) 382-404 discussion 404-7
2. Traish A.M., Goldstein I., and Kim N.N. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 52 (2007) 54-70
3. Kupelian V., Shabsigh R., Araujo A.B., O'Donnell A.B., and McKinlay J.B. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol 176 (2006) 222-226
4. Morley J.E., Perry III H.M., Kevorkian R.T., and Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 53 (2006) 424-429
5. Nieschlag E., Swerdloff R., Behre H.M., et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol 48 (2005) 1-4
6. Wespes E., Amar E., Hatzichristou D., et al. EAU guidelines on erectile dysfunction: an update. Eur Urol 49 (2006) 806-815
7. Montorsi F., and Oettel M. Testosterone and sleep-related erections: an overview. J Sex Med 2 (2005) 771-784
8. Guay A.T., Perez J.B., Jacobson J., and Newton R.A. Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 22 (2001) 793-797
9. Shabsigh R., Kaufman J.M., Steidle C., and Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172 (2004) 658-663
10. Morgentaler A. Testosterone and prostate cancer: an historical perspective on a modern myth. Eur Urol 50 (2006) 935-939